Pekeliling Tentang Langkah-Langkah Pengurangan Risiko Bagi Produk Yang Mengandungi Strontium Ranelate Susulan Risiko Kesan Advers Kardiovaskular
- Posted By Choo Sim Mei
- Hits: 6838
User Rating: 1 / 5
 |
 |
 |
 |
National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
- Email: npra@npra.gov.my
- Phone: +603-7883 5400
- Fax: +603-7956 2924, +603-7956 7075
 |
 |
 |
 |
More Links
DISCLAIMER
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.
Mobile Web :
Site Last Modified
- Last Modified: Friday 26 May 2023, 09:15:39.